Kim C. de Vries

Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial

Kim C. de Vries, Ruud C. Wortel, Esther Oomen‐de Hoop et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 56 citations

Urology, Radiation Medicine, Radiation Therapy +6

Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014

Paul M. Jeene, Kim C. de Vries, Johanna G. H. van Nes et al. · Acta Oncologica · 2017 · 38 citations · Full text

Significant tumor shift in patients treated with stereotactic radiosurgery for brain metastasis

Eline Hessen, L. D. van Buuren, Jasper Nijkamp et al. · Clinical and Translational Radiation Oncology · 2017 · 26 citations · Full text

The added value of a new high-performance ring-gantry CBCT imaging system for prostate cancer patients

Britt Kunnen, Agustinus J.A.J. van de Schoot, Kimm P. Fremeijer et al. · Radiotherapy and Oncology · 2024 · 23 citations

Urology, Added Value, Engineering +9

Largely reduced OAR doses, and planning and delivery times for challenging robotic SBRT cases, obtained with a novel optimizer

M. Gíżyńska, Linda Rossi, Wilhelm den Toom et al. · Journal of Applied Clinical Medical Physics · 2021 · 14 citations · Full text